ASCO 2019 | The clinical application of MRD testing in AML

Name: The clinical application of MRD testing in AML
Uploaded: 2019-06-01T22:44:20.000Z
Duration: 1 min 30 s
Description: Here, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, gives a background on the clinical application of measurable residual disease (MRD) testing for acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Michael Heuser • 1 Jun 2019

ASCO 2019

Acute Myeloid Leukemia Leukemia

Here, Michael Heuser, MD, of Hannover Medical School, Hanover, Germany, gives a background on the clinical application of measurable residual disease (MRD) testing for acute myeloid leukemia (AML). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.